Treatment of superior vena cava syndrome with recombinant tissue plasminogen activator in a sickle cell patient undergoing bone marrow transplantation

Pediatric Hematology and Oncology

Volumn 18, Issue 1, 2001, Pages 71-77

  Ramdas, Jagadeesh ^a   Haymon, Marie ^b   Ward, Kenneth ^b   Velez, Maria ^a   Yu, Lolie C ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

rt PA; Sickle cell; Superior vena cava

Indexed keywords

ALTEPLASE; CREATININE; NITROGEN; UREA;

ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AZYGOS VEIN; CASE REPORT; CREATININE BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; FACE EDEMA; FEMALE; HEMOFILTRATION; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; PHLEBOGRAPHY; SICKLE CELL ANEMIA; SUPERIOR CAVA VEIN SYNDROME; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL; URINE VOLUME; VENOUS REFLUX;

ADOLESCENT; ANEMIA, SICKLE CELL; BONE MARROW TRANSPLANTATION; FEMALE; HUMANS; RECOMBINANT PROTEINS; SUPERIOR VENA CAVA SYNDROME; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0035148465     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/088800101750059882     Document Type: Article

References (10)

1. Superior vena cava syndrome: A new entity
2. Etiology considerations in superior vena cava syndrome
3. Sickle cell disease
4. Endovascular treatment of superior vena cava syndrome without removing central catheter
5. Alteplase, recombinant
6. Treatment of superior vena cava thrombosis with recombinant tissue type plasminogen activator
7. Iatrogenic superior vena cava syndrome: Successful thrombolysis with recombinant tissue plasminogen activator
8. Tissue plasminogen activator for the treatment of thromboembolism in infants and children
9. Randomized controlled trial of tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism
10. Bone marrow transplantation for sickle cell disease